Publications by authors named "Jerry Collins"

Claim this Profile
A
A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors.
Sarah J Shin, Geraldine O'Sullivan Coyne, Shivaani Kummar, Sarah B Miller, Barry C Johnson, Jerry Collins

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.
Joel Morris, Mark W Kunkel, Stephen L White, Donn G Wishka, Omar D Lopez, Jerry M Collins

Mol Cancer Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case report of typhlitis during novel use of ropidoxuridine-capecitabine-radiotherapy for treatment-naïve rectal cancer.
Charles A Kunos, Richard Piekarz, Jerry M Collins, Timothy J Kinsella

Cancer Chemother Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROADMAPS: An Online Database of Response Data, Dosing Regimens, and Toxicities of Approved Oncology Drugs as Single Agents to Guide Preclinical In Vivo Studies.
Melinda G Hollingshead, Nathaniel Greenberg, Michelle Gottholm-Ahalt, Richard Camalier, Barry C Johnson, Jerry M Collins

Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd.
Joel Morris, Donn G Wishka, Omar D Lopez, Vladimir Rudchenko, Guangfei Huang, Jerry M Collins

Mol Cancer Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors.
Naoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, Jerry Collins, Joel M Reid

Oncotarget· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas.
Geraldine O'Sullivan Coyne, Shivaani Kummar, Robert S Meehan, Khanh Do, Jerry M Collins

Oncotarget· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas.
Long-Sheng Chang, Janet L Oblinger, Sarah S Burns, Jie Huang, Larry W Anderson, Jerry M Collins

Mol Cancer Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation.
Timothy Kinsella, Howard Safran, Susan Wiersma, Thomas DiPetrillo, Andrew Schumacher, Jerry M Collins

Clin Cancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution, Tumor Detection, and Radiation Dosimetry of F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid Tumors.
Colin R Young, Stephen Adler, Janet F Eary, M Liza Lindenberg, Paula M Jacobs, Jerry Collins

J Nucl Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythrofordins D and E, two new cassaine-type diterpenes from Erythrophleum suaveolens.
Tanja Grkovic, Jason R Evans, Rhone K Akee, Liang Guo, Myrtle Davis, Jerry M Collins

Bioorg Med Chem Lett· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile.
Giovanna Speranza, Larry Anderson, Alice P Chen, Khanh Do, Michelle Eugeni, Jerry Collins

Invest New Drugs· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.
Matthew P Goetz, Vera J Suman, Joel M Reid, Don W Northfelt, Michael A Mahr, Jerry M Collins

J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity.
Susan L Holbeck, Richard Camalier, James A Crowell, Jeevan Prasaad Govindharajulu, Melinda Hollingshead, Jerry M Collins

Cancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: F-FAU, F-FMAU, and F-FLT.
Christopher I McHugh, Jawana M Lawhorn-Crews, Dipenkumar Modi, Kirk A Douglas, Steven K Jones, Jerry M Collins

Cancer Imaging· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors.
Shivaani Kummar, Alice Chen, Martin Gutierrez, Thomas D Pfister, Lihua Wang, Jerry Collins

Cancer Chemother Pharmacol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program.
Richard Gorlick, E Anders Kolb, Stephen T Keir, John M Maris, Richard B Lock, Jerry Collins

Pediatr Blood Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors.
Khanh Do, Deborah Wilsker, Jiuping Ji, Jennifer Zlott, Tomoko Freshwater, Jerry Collins

J Clin Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors.
Khanh Do, Giovanna Speranza, Lun-Ching Chang, Eric C Polley, Rachel Bishop, Jerry Collins

Invest New Drugs· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies.
Melinda G Hollingshead, Luke H Stockwin, Sergio Y Alcoser, Dianne L Newton, Benjamin C Orsburn, Jerry Collins

BMC Genomics· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas.
Shivaani Kummar, Martin E Gutierrez, Lawrence W Anderson, Raymond W Klecker, Alice Chen, Jerry M Collins

Cancer Chemother Pharmacol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignancies.
Shivaani Kummar, Larry Anderson, Kimberly Hill, Eva Majerova, Deborah Allen, Jerry M Collins

Clin Cancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas.
Sook Ryun Park, Giovanna Speranza, Richard Piekarz, John J Wright, Robert J Kinders, Jerry Collins

Cancer Chemother Pharmacol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors.
Giovanna Speranza, Martin E Gutierrez, Shivaani Kummar, John M Strong, Robert J Parker, Jerry Collins

Cancer Chemother Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas.
Shivaani Kummar, Martin E Gutierrez, Alice Chen, Ismail B Turkbey, Deborah Allen, Jerry Collins

Eur J Cancer· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis